Home NDC 50458-840 NUCYNTA
Product NDC 50458-840
11-digit product format 504580840
Labeler code 50458
Product ID 50458-840_926544cc-122c-4f9f-9434-a886827b0871
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tapentadol hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Janssen Pharmaceuticals, Inc.
Application NDA022304
Marketing category NDA
Marketing start 2009-06-01
Marketing end 2020-03-31
Substance TAPENTADOL HYDROCHLORIDE
Active strength 100 mg/1
Pharmacologic classes Opioid Agonist [EPC],Opioid Agonists [MoA]
DEA schedule CII
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022304-001 NUCYNTA TAPENTADOL HYDROCHLORIDE EQ 50MG BASE TABLET / ORAL AB RLD 2008-11-20 N022304-002 NUCYNTA TAPENTADOL HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL AB RLD 2008-11-20 N022304-003 NUCYNTA TAPENTADOL HYDROCHLORIDE EQ 100MG BASE TABLET / ORAL AB RLD, RS 2008-11-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL AB RLD 2008-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL AB RLD 2008-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL AB RLD, RS 2008-11-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022304-002 NUCYNTA EQ 75MG BASE TABLET / ORAL RLD 2008-11-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022304-003 NUCYNTA EQ 100MG BASE TABLET / ORAL RLD, RS 2008-11-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022304-001 NUCYNTA EQ 50MG BASE TABLET / ORAL RLD 2008-11-20 8072bd15b7f6…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 6 · 201 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-001 7994364*PED 2025-12-27 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-002 7994364*PED 2025-12-27 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022304-003 7994364*PED 2025-12-27 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-001 7994364*PED 2025-12-27 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-002 7994364*PED 2025-12-27 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022304-003 7994364*PED 2025-12-27 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-001 7994364*PED 2025-12-27 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-002 7994364*PED 2025-12-27 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022304-003 7994364*PED 2025-12-27 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-001 7994364*PED 2025-12-27 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-002 7994364*PED 2025-12-27 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022304-003 7994364*PED 2025-12-27 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-001 7994364*PED 2025-12-27 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-002 7994364*PED 2025-12-27 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022304-003 7994364*PED 2025-12-27 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-001 7994364*PED 2025-12-27 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-002 7994364*PED 2025-12-27 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-003 7994364 2025-06-27 U-931 Drug substance, Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022304-003 7994364*PED 2025-12-27 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-001 7994364 2025-06-27 U-931 Drug substance, Drug product 2011-09-02 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-001 7994364*PED 2025-12-27 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-002 7994364 2025-06-27 U-931 Drug substance, Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022304-002 7994364*PED 2025-12-27 Pediatric extension 5bbf6a4d5a75…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 96 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded tapentadol hydrochloride ACTIVE INGREDIENT 71204KII53 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 tapentadol ACTIVE MOIETY H8A007M585 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 aluminum oxide INACTIVE INGREDIENT LMI26O6933 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 magnesium stearate INACTIVE INGREDIENT 70097M6I30 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 polyethylene glycols INACTIVE INGREDIENT 3WJQ0SDW1A NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 polyvinyl alcohol INACTIVE INGREDIENT 532B59J990 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 povidones INACTIVE INGREDIENT FZ989GH94E NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 talc INACTIVE INGREDIENT 7SEV7J4R1U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] 8 tapentadol hydrochloride ACTIVE INGREDIENT 71204KII53 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 TAPENTADOL HYDROCHLORIDE ACTIVE INGREDIENT 71204KII53 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 tapentadol ACTIVE MOIETY H8A007M585 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 TAPENTADOL ACTIVE MOIETY H8A007M585 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 aluminum oxide INACTIVE INGREDIENT LMI26O6933 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 magnesium stearate INACTIVE INGREDIENT 70097M6I30 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 polyethylene glycol INACTIVE INGREDIENT 3WJQ0SDW1A NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 POLYETHYLENE GLYCOL INACTIVE INGREDIENT 3WJQ0SDW1A NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 polyvinyl alcohol INACTIVE INGREDIENT 532B59J990 NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 povidone INACTIVE INGREDIENT FZ989GH94E NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 POVIDONE INACTIVE INGREDIENT FZ989GH94E NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 talc INACTIVE INGREDIENT 7SEV7J4R1U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [STAT RX USA] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings#